CNO Financial Group(CNO) - 2023 Q3 - Earnings Call Presentation

NII allocated to products benefiting from multiple quarters of +6% NMRs and growing asset base 3Q23 $40 million of share repurchases Operating ROE1 , as adjusted, of 8.5$44.5 $46.5$47.6 $47.2 Med supp – runoff of legacy block LTC – favorable claims experience in 3Q 2023 Rising earnings power with stable credit trend Capital and liquidity remain above target levels (dollars in millions) Target leverage of 25 - 28% Debt covenant ceiling of 35% 2021 | --- | --- | |----------------------------------------- ...